Potential biases in the classification, analysis and interpretations in cross-sectional study: commentaries - surrounding the article ""resting heart rate: its correlations and potential for screening metabolic dysfunctions in adolescents""

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Citação
BMC PEDIATRICS, v.14, article ID 117, 4p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Resting heart rate reflects sympathetic nerve activity. A significant association between resting heart rate (HR) and all causes of cardiovascular mortality has been reported by some epidemiologic studies. Despite suggestive evidence, resting heart rate (RHR) has not been formally explored as a prognostic factor and potential therapeutic outcome and, therefore, is not generally accepted in adolescents. Discussion: The core of the debate is the methodological aspects used in ""Resting heart rate: its correlations and potential for screening metabolic dysfunctions in adolescents""; the points are: cutoff used for cluster RHR, two different statistical models used to analyze the same set of variables, one for continuous data, and another for categorical data; interpretation of p-value < 0.05, sampling process involving two random stages, analysis of design effect and the parameters of screening tests. Summary: Aspects that must be taken into account for evaluation of a screening test to measure the potential for discrimination for a common variable (population with outcome vs. no outcome population), the main indicators are: sensitivity, specificity, accuracy, positive predictive value and negative predictive value. The measures of argumentation equality (CI) or difference (p-valor) are important to validate these indicators but do not indicate quality of screening.
Palavras-chave
Resting heart rate, Screening test, P-value, High glucose, High triglycerides
Referências
  1. Alvarez GE, 2002, CIRCULATION, V106, P2533, DOI 10.1161/01.CIR.0000041244.79165.25
  2. AXELSON O, 1995, OCCUP ENVIRON MED, V52, P494
  3. AXELSON O, 1994, OCCUP ENVIRON MED, V51, P574
  4. Barros Aluísio J. D., 2002, Ciênc. saúde coletiva, V7, P709, DOI 10.1590/S1413-81232002000400008
  5. Barros Aluísio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21
  6. Bemelmans RHH, 2013, INT J CARDIOL, V168, P1410, DOI 10.1016/j.ijcard.2012.12.043
  7. Breslow NE, 1980, STAT METHODS CANC RE
  8. Brumfiel B, 2008, NATURE, V455, P1027
  9. Cuckle H, 2004, OBSTET GYNECOL, V6, P21, DOI 10.1576/toag.6.1.21.26976
  10. Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49
  11. Fernandes RA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-48
  12. Fernandes RA, 2011, J PEDIATR-US, V158, P634, DOI 10.1016/j.jpeds.2010.10.007
  13. Goodman SN, 1999, ANN INTERN MED, V130, P995
  14. Grassi G, 1998, J HYPERTENS, V16, P1635, DOI 10.1097/00004872-199816110-00010
  15. Greenhalgh T, 1997, BRIT MED J, V315, P364
  16. Grimes DA, 2002, LANCET, V359, P881, DOI 10.1016/S0140-6736(02)07948-5
  17. Heo MS, 2010, STAT MED, V29, P382, DOI 10.1002/sim.3806
  18. Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8
  19. Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012
  20. Kish L, 1965, SURVEY SAMPLING
  21. KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166
  22. LEE J, 1993, BRIT J IND MED, V50, P861
  23. Muntner P, 2004, JAMA-J AM MED ASSOC, V291, P2107, DOI 10.1001/jama.291.17.2107
  24. Nielsen C, 1999, MED CLIN N AM, V83, P1323, DOI 10.1016/S0025-7125(05)70169-3
  25. Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312
  26. Palatini P, 2004, CLIN EXP HYPERTENS, V26, P637, DOI 10.1081/CEH-200031959
  27. Pausova Z, 2012, HYPERTENSION, V59, P572, DOI 10.1161/HYPERTENSIONAHA.111.180372
  28. Pausova Z, 2010, HYPERTENSION, V55, P706, DOI 10.1161/HYPERTENSIONAHA.109.146720
  29. Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555
  30. Polderman J, 2011, PUBLIC HEALTH NUTR, V14, P1064, DOI 10.1017/S1368980010003666
  31. Schlesselman J. J., 1982, CASE CONTROL STUDIES
  32. Spear B, 1995, ADOLESCENT NUTR ASSE
  33. SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615
  34. Weise M, 2002, J CLIN ENDOCR METAB, V87, P5038, DOI 10.1210/jc.2002-020590
  35. Ziliak ST, 2008, CULT STAT SIGNIFICAN